Taken together, our study suggested that expression level of RP11-273G15.2 was highly correlated with IFN scores and disease activity in patients with SLE and it might work as a biomarker for SLE diagnosis and disease activity monitoring. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.